These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 25072357

  • 21. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J, Cook JA, O'Connor M, Zingarelli B.
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [Abstract] [Full Text] [Related]

  • 22. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM.
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 24. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells.
    Weber SM, Scarim AL, Corbett JA.
    Am J Physiol Endocrinol Metab; 2004 Mar 01; 286(3):E329-36. PubMed ID: 14600076
    [Abstract] [Full Text] [Related]

  • 25. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005 Mar 01; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 26. 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells.
    Rajasingh J, Bright JJ.
    Exp Cell Res; 2006 Aug 01; 312(13):2538-46. PubMed ID: 16737695
    [Abstract] [Full Text] [Related]

  • 27. Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2).
    Zhang YJ, Yang X, Kong QY, Zhang YF, Chen WY, Dong XQ, Li XY, Yu XQ.
    Am J Nephrol; 2006 Aug 01; 26(4):356-62. PubMed ID: 16864989
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Ichite N, Singh M.
    Anticancer Drugs; 2007 Jan 01; 18(1):65-78. PubMed ID: 17159504
    [Abstract] [Full Text] [Related]

  • 30. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep 01; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

  • 31. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct 01; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 32. 15-Deoxy-Δ12,14-prostaglandin J2 ameliorates dextran sulfate sodium-induced colitis in mice through heme oxygenase-1 induction.
    Takagi T, Naito Y, Mizushima K, Hirai Y, Kamada K, Uchiyama K, Handa O, Ishikawa T, Itoh Y.
    Arch Biochem Biophys; 2019 Nov 30; 677():108183. PubMed ID: 31704099
    [Abstract] [Full Text] [Related]

  • 33. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR, Kim HJ, Lee SK, Ma GT, Park KK, Chung WY.
    PLoS One; 2015 Nov 30; 10(4):e0122764. PubMed ID: 25859665
    [Abstract] [Full Text] [Related]

  • 34. 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells.
    Kang ES, Hwang JS, Ham SA, Park MH, Kim GH, Paek KS, Yoo T, Lee WJ, Kang KR, Lee JH, Choi YJ, Seo HG.
    Free Radic Res; 2014 Feb 30; 48(2):218-29. PubMed ID: 24180671
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
    Siavash H, Nikitakis NG, Sauk JJ.
    Cancer Lett; 2004 Jul 28; 211(1):97-103. PubMed ID: 15194221
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Sep 28; 140(2):366-76. PubMed ID: 12970094
    [Abstract] [Full Text] [Related]

  • 39. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R, Mitchell SH, Tindall DJ, Young CY.
    Cell Growth Differ; 2000 Jan 28; 11(1):49-61. PubMed ID: 10672903
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.